You just read:

Regeneron Provides Regulatory Update on EYLEA® (aflibercept) Injection sBLA in Wet Age-Related Macular Degeneration

News provided by

Regeneron Pharmaceuticals, Inc.

Aug 13, 2018, 07:00 ET